News
SYK
240.77
+2.94%
6.88
Investors in Stryker (NYSE:SYK) have made a notable return of 58% over the past five years
Passive investing in index funds can generate returns that roughly match the overall market. But you can do a lot...
Simply Wall St. · 1d ago
What Is Stryker Corporation's (NYSE:SYK) Share Price Doing?
Let's talk about the popular Stryker Corporation ( NYSE:SYK ). The company's shares saw a double-digit share price rise...
Simply Wall St. · 5d ago
Earnings Tell The Story For Stryker Corporation (NYSE:SYK)
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 14x, you may...
Simply Wall St. · 11/18 12:02
Stryker (NYSE:SYK) stock performs better than its underlying earnings growth over last five years
When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, you'd...
Simply Wall St. · 11/13 12:00
Why Uber Will Dominate Lyft In Ride-Hailing Space And This MedTech Company Featured On CNBC's 'Final Trades'
Benzinga · 11/09 13:32
As Stryker Corporation's (NYSE:SYK)) market cap dropped by US$3.9b, insiders who sold US$1.1m worth of stock were able to offset their losses
Over the past year, insiders sold US$1.1m worth of Stryker Corporation ( NYSE:SYK ) stock at an average price of US$251...
Simply Wall St. · 11/09 11:00
Insider Sell: Stryker
Insider Sell: Stryker
MT Newswires · 11/04 16:20
Stryker to participate in the 5th Annual Evercore ISI HealthCONx Conference
Kalamazoo, Michigan, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022. Kevin Lobo, Chair and Chief Executive Officer and Jason Beach, Vice President, In...
GlobeNewswire · 11/03 20:05
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
Benzinga · 11/02 09:07
--DA Davidson Adjusts Stryker Price Target to $250 From $260, Maintains Buy Rating
--DA Davidson Adjusts Stryker Price Target to $250 From $260, Maintains Buy Rating
MT Newswires · 11/02 07:26
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session
Benzinga · 11/01 16:38
Goodyear Tire, Catalent, Zebra Technologies And Some Other Big Stocks Moving Lower On Tuesday
Benzinga · 11/01 15:36
Where Stryker Stands With Analysts
Benzinga · 11/01 15:04
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
Benzinga · 11/01 14:27
Stryker cut to Hold at Canaccord Genuity after Q3 earnings miss
Seekingalpha · 11/01 13:18
Alibaba To $125? Plus This Analyst Slashes PT On Argo Blockchain By 90%
Benzinga · 11/01 12:54
Wells Fargo Maintains Overweight on Stryker, Raises Price Target to $248
Benzinga · 11/01 12:20
RBC Capital Maintains Sector Perform on Stryker, Lowers Price Target to $240
Benzinga · 11/01 12:19
Stryker Reports Q3 Earnings Miss Due To High Component Prices, Cuts Full Year Profit Guidance
Benzinga · 11/01 11:59
More
Webull provides a variety of real-time SYK stock news. You can receive the latest news about Stryker Corp through multiple platforms. This information may help you make smarter investment decisions.
About SYK
Stryker Corporation (Stryker) is a medical technology company. The Company offers products and services in Medical and Surgical, Neurotechnology, Orthopaedics, and Spine that help improve patient and hospital outcomes. Its products are sold in approximately 75 countries through Company-owned subsidiaries and branches, as well as, third-party dealers and distributors. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a range of medical specialties. Its business segments include MedSurg and Neurotechnology and Orthopaedics and Spine. Its subsidiaries include Alcott Indemnity Company, Arrinex, Inc., Berchtold Corporation, and BioMimetic Therapeutics, LLC.